Japan · Delayed Price · Currency is JPY Medikit Statistics
Total Valuation
Medikit has a market cap or net worth of JPY 40.63 billion. The enterprise value is 19.69 billion.
| Market Cap | 40.63B |
| Enterprise Value | 19.69B |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Medikit has 14.48 million shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 7.96% |
| Owned by Institutions (%) | 17.40% |
| Float | 4.55M |
Valuation Ratios
The trailing PE ratio is 13.60.
| PE Ratio | 13.60 |
| Forward PE | n/a |
| PS Ratio | 1.71 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 31.42 |
| P/OCF Ratio | 8.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.12, with an EV/FCF ratio of 15.23.
| EV / Earnings | 6.55 |
| EV / Sales | 0.83 |
| EV / EBITDA | 3.12 |
| EV / EBIT | 4.61 |
| EV / FCF | 15.23 |
Financial Position
The company has a current ratio of 6.25, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.25 |
| Quick Ratio | 4.91 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 610.14 |
Financial Efficiency
Return on equity (ROE) is 6.54% and return on invested capital (ROIC) is 11.09%.
| Return on Equity (ROE) | 6.54% |
| Return on Assets (ROA) | 5.05% |
| Return on Invested Capital (ROIC) | 11.09% |
| Return on Capital Employed (ROCE) | 8.91% |
| Weighted Average Cost of Capital (WACC) | 4.78% |
| Revenue Per Employee | 24.05M |
| Profits Per Employee | 3.04M |
| Employee Count | 989 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, Medikit has paid 1.51 billion in taxes.
| Income Tax | 1.51B |
| Effective Tax Rate | 33.38% |
Stock Price Statistics
The stock price has increased by +12.24% in the last 52 weeks. The beta is 0.09, so Medikit's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +12.24% |
| 50-Day Moving Average | 2,962.98 |
| 200-Day Moving Average | 2,846.48 |
| Relative Strength Index (RSI) | 17.13 |
| Average Volume (20 Days) | 1,690 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medikit had revenue of JPY 23.78 billion and earned 3.01 billion in profits. Earnings per share was 206.36.
| Revenue | 23.78B |
| Gross Profit | 9.01B |
| Operating Income | 4.27B |
| Pretax Income | 4.51B |
| Net Income | 3.01B |
| EBITDA | 6.31B |
| EBIT | 4.27B |
| Earnings Per Share (EPS) | 206.36 |
Balance Sheet
The company has 20.95 billion in cash and 18.00 million in debt, with a net cash position of 20.93 billion or 1,445.91 per share.
| Cash & Cash Equivalents | 20.95B |
| Total Debt | 18.00M |
| Net Cash | 20.93B |
| Net Cash Per Share | 1,445.91 |
| Equity (Book Value) | 46.78B |
| Book Value Per Share | 3,229.12 |
| Working Capital | 27.90B |
Cash Flow
In the last 12 months, operating cash flow was 4.73 billion and capital expenditures -3.44 billion, giving a free cash flow of 1.29 billion.
| Operating Cash Flow | 4.73B |
| Capital Expenditures | -3.44B |
| Depreciation & Amortization | 2.04B |
| Net Borrowing | n/a |
| Free Cash Flow | 1.29B |
| FCF Per Share | 89.31 |
Margins
Gross margin is 37.87%, with operating and profit margins of 17.96% and 12.64%.
| Gross Margin | 37.87% |
| Operating Margin | 17.96% |
| Pretax Margin | 18.97% |
| Profit Margin | 12.64% |
| EBITDA Margin | 26.53% |
| EBIT Margin | 17.96% |
| FCF Margin | 5.44% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 46.84% |
| Buyback Yield | 1.12% |
| Shareholder Yield | 4.61% |
| Earnings Yield | 7.40% |
| FCF Yield | 3.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Medikit has an Altman Z-Score of 6.03 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.03 |
| Piotroski F-Score | 6 |